Amplity Health, a partner of worldwide healthcare firms and investment of the Altamont Capital Partners, has revealed that it is merging with medical communications company The Lynx Group. This synergy means that consumers and clients will be provided with comprehensive commercial and medical solutions. This comes just weeks after Amplity’s acquisition of Middleton Access in December.
CEO and President of Amplity, Michael A. Griffith, expressed that “Medical and commercial strategies for our biopharmaceutical clients have become highly specialized. Lynx engages with a unique combination of oncology and complex drug experts to create proprietary medical communications, produce topical and relevant events with their association partners, and develop high-quality scientific messages and publications that shape drug development and launch. In the past 3 years alone, Lynx has participated in 80% of all successful oncology brand launches.”
“Amplity Health, a partner of worldwide healthcare firms and investment of the Altamont Capital Partners, has revealed that it is merging with medical communications company The Lynx Group.“
CEO and President of The Lynx Group, Brian Tyburski, also commented that “We found that the leadership of both Amplity and Altamont share our perspectives on the future of medical and commercial solutions. Taken together, our shared vision is to build proprietary data sets and insights that inform client decisions.”
He continued: “We will accelerate investment in new technologies to better engage our proprietary expert networks, to sharpen digital content and channels, and to expand strategic and market access consultancy services. Importantly, the combination of our capabilities allows us to bundle and manage complex services that are purchased separately today.”
© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.See all the latest jobs in Healthcare Communications